相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。From LI-RADS Classification to HCC Pathology: A Retrospective Single-Institution Analysis of Clinico-Pathological Features Affecting Oncological Outcomes after Curative Surgery
Leonardo Centonze et al.
DIAGNOSTICS (2022)
Dynamic Changes in Pre- and Postoperative Levels of Inflammatory Markers and Their Effects on the Prognosis of Patients with Gastric Cancer
Jian-Xian Lin et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2021)
Epidemiology of Hepatocellular Carcinoma
Katherine A. McGlynn et al.
HEPATOLOGY (2021)
Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial
Tae Hyun Kim et al.
JOURNAL OF HEPATOLOGY (2021)
Prediction of early recurrence of hepatocellular carcinoma after resection using digital pathology images assessed by machine learning
Akira Saito et al.
MODERN PATHOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Clinical importance of the absolute count of neutrophils, lymphocytes, monocytes, and platelets in newly diagnosed hepatocellular carcinoma
Jeong Il Yu et al.
SCIENTIFIC REPORTS (2021)
Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis
Chih-Wen Lin et al.
BMC GASTROENTEROLOGY (2020)
Clinical Significance of Systemic Inflammation Markers in Newly Diagnosed, Previously Untreated Hepatocellular Carcinoma
Jeong Il Yu et al.
CANCERS (2020)
Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular Carcinoma
Ming-Da Wang et al.
ONCOLOGIST (2020)
Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis
Yang-Xun Pan et al.
FRONTIERS IN ONCOLOGY (2020)
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 29, pg iv238, 2018)
A. Vogel et al.
ANNALS OF ONCOLOGY (2019)
Prognostic impact of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation in patients with unresectable hepatocellular carcinoma: Comparison with TACE alone using decision-tree analysis after propensity score matching
Shigeo Shimose et al.
HEPATOLOGY RESEARCH (2019)
A simplified prediction model for early intrahepatic recurrence after hepatectomy for patients with unilobar hepatocellular carcinoma without macroscopic vascular invasion: An implication for adjuvant therapy and postoperative surveillance
Kelvin K. Ng et al.
SURGICAL ONCOLOGY-OXFORD (2019)
Transarterial Chemoembolization Combined with Radiofrequency Ablation in the Treatment of Stage B1 Intermediate Hepatocellular Carcinoma
Furong Liu et al.
JOURNAL OF ONCOLOGY (2019)
Pre/Post-Treatment Dynamic of Inflammatory Markers Has Prognostic Value in Patients with Small Hepatocellular Carcinoma Managed by Stereotactic Body Radiation Therapy
Yuan Zhuang et al.
CANCER MANAGEMENT AND RESEARCH (2019)
2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
Joong-Won Park et al.
KOREAN JOURNAL OF RADIOLOGY (2019)
Comparison of macrovascular invasion-free survival in early-intermediate hepatocellular carcinoma after different interventions: A propensity score-based analysis
Yao Liu et al.
JOURNAL OF CANCER (2019)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
Chung-Kwe Wang
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2018)
Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients
Monica Khunger et al.
PLOS ONE (2018)
The diagnosis and treatment of hepatocellular carcinoma
Justin Hartke et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2017)
The pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with hepatocellular carcinoma: A meta-analysis
Wei Song et al.
SCIENTIFIC REPORTS (2017)
Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review
Jun Zheng et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Radiofrequency ablation combined with transarterial chemoembolization versus hepatectomy for patients with hepatocellular carcinoma within Milan criteria: a retrospective case-control study
A. K. Bholee et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2017)
A Review and Update of Treatment Options and Controversies in the Management of Hepatocellular Carcinoma
Mashaal Dhir et al.
ANNALS OF SURGERY (2016)
Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy
Yue Liu et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2016)
Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studies
Xingshun Qi et al.
ONCOTARGET (2016)
2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma
GUT AND LIVER (2015)
Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy
Yusuke Yamamoto et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
The evolving epidemiology of hepatocellular carcinoma: a global perspective
Michael C. Wallace et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis
Wei-Kai Xiao et al.
BMC CANCER (2014)
Cancer-related inflammation and treatment effectiveness
Connie I. Diakos et al.
LANCET ONCOLOGY (2014)
Prognostic factors for hepatocellular carcinoma recurrence
Antonio Colecchia et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Preoperative Neutrophil-to-Lymphocyte Ratio Is a Predictor of Survival After Hepatectomy for Hepatocellular Carcinoma A Retrospective Analysis
Yohei Mano et al.
ANNALS OF SURGERY (2013)
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
Eran Elinav et al.
NATURE REVIEWS CANCER (2013)
Obesity, inflammation, and liver cancer
Beicheng Sun et al.
JOURNAL OF HEPATOLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
A Prospective Clinical Study on Early Recurrence of Hepatocellular Carcinoma After Hepatectomy
Xin Lu et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma
Jung Ho Park et al.
AMERICAN JOURNAL OF SURGERY (2006)
Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes
SA Shah et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2006)
Early and late recurrence after liver resection for hepatocellular carcinoma - Prognostic and therapeutic implications
N Portolani et al.
ANNALS OF SURGERY (2006)
Assessment of optimal selected prognostic factors
B Lausen et al.
BIOMETRICAL JOURNAL (2004)
Risk factors contributing to early and date phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
H Imamura et al.
JOURNAL OF HEPATOLOGY (2003)
分享论文
